Selected article for: "antiviral drug development and drug development"
Author: Ding, Ronghua; Long, Jinzhao; Yuan, Mingzhu; Jin, Yuefei; Yang, Haiyan; Chen, Mengshi; Chen, Shuaiyin; Duan, Guangcai
Title: CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
  • Cord-id: 2aie6w6g
  • Document date: 2021_4_23
    • ID: 2aie6w6g
    Snippet: The continued global pandemic of coronavirus disease 2019 (COVID-19) poses a serious threat to global public health and social stability and it has become a serious global public health problem. Unfortunately, existing diagnostic and therapeutic approaches for the prevention and control of COVID-19 have many shortcomings. In recent years, the emerging CRISPR/Cas technology can complement the problems of traditional methods. Biological tools based on CRISPR/Cas systems have been widely used in bi
    Document: The continued global pandemic of coronavirus disease 2019 (COVID-19) poses a serious threat to global public health and social stability and it has become a serious global public health problem. Unfortunately, existing diagnostic and therapeutic approaches for the prevention and control of COVID-19 have many shortcomings. In recent years, the emerging CRISPR/Cas technology can complement the problems of traditional methods. Biological tools based on CRISPR/Cas systems have been widely used in biomedicine. In particular, they are advantageous in pathogen detection, clinical antiviral therapy, drug, and vaccine development. Therefore, CRISPR/Cas technology may have great potential for application in the prevention and control of COVID-19 and emerging infectious diseases in the future. This article summarizes the existing applications of CRISPR/Cas technology in infectious diseases with the aim of providing effective strategies for the prevention and control of COVID-19 and other emerging infectious diseases in the future.

    Search related documents:
    Co phrase search for related documents
    • accurate highly sensitive and lod detection: 1, 2, 3, 4, 5
    • accurate highly sensitive and lod detection limit: 1, 2, 3, 4, 5
    • accurate highly sensitive detection and acute respiratory syndrome: 1, 2, 3, 4
    • accurate highly sensitive detection and lod detection: 1, 2, 3
    • accurate highly sensitive detection and lod detection limit: 1, 2, 3
    • accurately quickly and acute respiratory syndrome: 1, 2, 3, 4
    • acid detection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid detection and lod detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acid detection and lod detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acid detection and low frequency: 1
    • acid detection method and acute respiratory syndrome: 1, 2
    • acid extraction and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid extraction and lod detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acid extraction and lod detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • actively research and acute respiratory syndrome: 1, 2
    • actively research and low frequency: 1
    • acute respiratory syndrome and locus mutation: 1
    • acute respiratory syndrome and lod detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lod detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25